Clinical Trial Update: A Study of Naltrexone SR/ Bupropion SR in Overweight and Obese Subjects Who Are Nicotine-Dependent [Phase 2]

View source ↗

Summary

Phase 2 trial of Naltrexone SR/Bupropion SR for overweight and nicotine-dependent individuals has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Obesity
• Overweight

Drugs mentioned

• Naltrexone SR/Bupropion SR (naltrexone/bupropion sustained-release)

Snippet

Sponsor: Orexigen Therapeutics, Inc | Conditions: Nicotine Dependence, Overweight | Phase 2 | Status: COMPLETED